Nishi Y, Zhang X, Jeong J, et al. A direct fate exclusion mechanism by Sonic hedgehog-regulated transcriptional repressors. Development. 2015;142(19):3286-93. doi:10.1242/dev.124636
Deribe YL, Shi Y, Rai K, et al. Truncating PREX2 mutations activate its GEF activity and alter gene expression regulation in NRAS-mutant melanoma. Proc Natl Acad Sci U S A. 2016;113(9):E1296-305. doi:10.1073/pnas.1513801113
Cancer Genome Atlas Research Network, Kandoth C, Schultz N, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67-73. doi:10.1038/nature12113
Wagner BK. Grand challenge commentary: Chemical transdifferentiation and regenerative medicine. Nat Chem Biol. 2010;6(12):877-9. doi:10.1038/nchembio.472
Fröhling S, Scholl C, Levine RL, et al. Identification of driver and passenger mutations of FLT3 by high-throughput DNA sequence analysis and functional assessment of candidate alleles. Cancer Cell. 2007;12(6):501-13. doi:10.1016/j.ccr.2007.11.005
Boulbes D, Chen CH, Shaikenov T, et al. Rictor phosphorylation on the Thr-1135 site does not require mammalian target of rapamycin complex 2. Mol Cancer Res. 2010;8(6):896-906. doi:10.1158/1541-7786.MCR-09-0409
Shay T, Kang J. Immunological Genome Project and systems immunology. Trends Immunol. 2013;34(12):602-9. doi:10.1016/j.it.2013.03.004
Chmielecki J, Meyerson M. DNA sequencing of cancer: what have we learned?. Annu Rev Med. 2014;65:63-79. doi:10.1146/annurev-med-060712-200152
Bar-Peled L, Sabatini DM. Regulation of mTORC1 by amino acids. Trends Cell Biol. 2014;24(7):400-6. doi:10.1016/j.tcb.2014.03.003
Mäkinen VP, Civelek M, Meng Q, et al. Integrative genomics reveals novel molecular pathways and gene networks for coronary artery disease. PLoS Genet. 2014;10(7):e1004502. doi:10.1371/journal.pgen.1004502